Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03412929 · ClinicalTrials.gov registry record · NA
A Clinical Evaluation of a Honey Impregnated Dressing at Removing Necrotic Tissue From Chronic Wounds
A NA study, sponsored by Medline Industries.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03412929: Clinical Trial NA study, sponsored by Medline Industries.
NCT03412929 is a NA study that was terminated before completion, run by Medline Industries. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03412929, a NA study, was terminated before completion, sponsored by Medline Industries.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a honey-impregnated wound dressing at removing necrotic tissue in subjects with chronic foot or ankle wounds.
Primary Outcome
The percent change in necrotic tissue will serve as the primary endpoint.
Interventions
- DEVICE Honey Impregnated Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2019-05-28 |
| Phase | NA |
Why NCT03412929 stopped before completion
NCT03412929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Honey Impregnated Dressing is the first listed.
NCT03412929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03412929 about?
NCT03412929 is a clinical study titled "A Clinical Evaluation of a Honey Impregnated Dressing at Removing Necrotic Tissue From Chronic Wounds". The purpose of this study is to evaluate the effectiveness of a honey-impregnated wound dressing at removing necrotic tissue in subjects with chronic foot or ankle wounds.
What is the current status of trial NCT03412929?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2018-01-10. Estimated completion is 2019-05-28.
What interventions are being tested in trial NCT03412929?
The interventions under investigation include: Honey Impregnated Dressing (DEVICE).
Who is sponsoring clinical trial NCT03412929?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03412929's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI